ATE116854T1 - Verwendung von buspiron in schlaf-apnoe. - Google Patents

Verwendung von buspiron in schlaf-apnoe.

Info

Publication number: ATE116854T1
Authority: AT; Austria
Prior art keywords: buspirone; sleep apnea; useful; treatment; pharmaceutically acceptable
Prior art date: 1990-02-12

Application number

AT91101888T

Other languages

English (en)

Inventor

William C Dement

Mark R Rosekind

Jeffrey L Schwimmer

Original Assignee

Bristol Myers Squibb Co

Univ Stanford

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-02-12

Filing date

1991-02-11

Publication date

1995-01-15

1991-02-11 Application filed by Bristol Myers Squibb Co, Univ Stanford filed Critical Bristol Myers Squibb Co

1995-01-15 Application granted granted Critical

1995-01-15 Publication of ATE116854T1 publication Critical patent/ATE116854T1/de

Links

QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 title abstract 2
229960002495 buspirone Drugs 0.000 title abstract 2
201000002859 sleep apnea Diseases 0.000 title abstract 2
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT91101888T 1990-02-12 1991-02-11 Verwendung von buspiron in schlaf-apnoe. ATE116854T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US47980390A	1990-02-12	1990-02-12

Publications (1)

Publication Number	Publication Date
ATE116854T1 true ATE116854T1 (de)	1995-01-15

Family

ID=23905511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91101888T ATE116854T1 (de)	1990-02-12	1991-02-11	Verwendung von buspiron in schlaf-apnoe.

Country Status (12)

Country	Link
EP (1)	EP0442423B1 (de)
JP (1)	JP3168543B2 (de)
KR (1)	KR910015300A (de)
AT (1)	ATE116854T1 (de)
CA (1)	CA2036055A1 (de)
DE (1)	DE69106543T2 (de)
DK (1)	DK0442423T3 (de)
ES (1)	ES2069758T3 (de)
GR (1)	GR3015716T3 (de)
HK (1)	HK1005016A1 (de)
HU (1)	HUT56496A (de)
IL (1)	IL97054A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5631017A (en) *	1993-03-26	1997-05-20	Beth Israel Deaconess Medical Center, Inc.	Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) *	1993-03-26	1996-01-16	Beth Israel Hospital Association	Buspirone as a systemic immunosuppressant
US5637314A (en) *	1995-06-07	1997-06-10	Beth Israel Deaconess Medical Center, Inc.	Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US7160898B2 (en)	2001-12-14	2007-01-09	Board Of Trustees Of The University Of Illinois	Pharmacological treatment for sleep apnea
CA2321900C (en)	1998-02-27	2011-07-19	The Board Of Trustees Of The University Of Illinois	Agents with serotonin-related activity for the treatment for sleep apnea
US8134029B2 (en)	2002-09-16	2012-03-13	Sunovion Pharmaceuticals Inc.	Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
CA2590802A1 (en)	2004-12-20	2006-06-29	Collegium Pharmaceutical, Inc.	Pharmaceutical compositions for sleep disorders
CA2614282A1 (en)	2005-07-06	2007-01-11	Sepracor Inc.	Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
PT2816024T (pt)	2006-03-31	2017-10-20	Sunovion Pharmaceuticals Inc	Aminas quirais
US20120077818A1 (en) *	2009-05-13	2012-03-29	Sunovion Pharmaceuticals Inc.	Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof

1991
- 1991-01-25 IL IL9705491A patent/IL97054A/en not_active IP Right Cessation
- 1991-02-06 JP JP10059991A patent/JP3168543B2/ja not_active Expired - Fee Related
- 1991-02-08 CA CA002036055A patent/CA2036055A1/en not_active Abandoned
- 1991-02-11 KR KR1019910002288A patent/KR910015300A/ko not_active Withdrawn
- 1991-02-11 EP EP91101888A patent/EP0442423B1/de not_active Expired - Lifetime
- 1991-02-11 AT AT91101888T patent/ATE116854T1/de not_active IP Right Cessation
- 1991-02-11 HU HU91436A patent/HUT56496A/hu unknown
- 1991-02-11 ES ES91101888T patent/ES2069758T3/es not_active Expired - Lifetime
- 1991-02-11 DE DE69106543T patent/DE69106543T2/de not_active Expired - Fee Related
- 1991-02-11 DK DK91101888.5T patent/DK0442423T3/da active
1995
- 1995-04-07 GR GR950400847T patent/GR3015716T3/el unknown
1998
- 1998-05-15 HK HK98104204A patent/HK1005016A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69106543D1 (de)	1995-02-23
DK0442423T3 (da)	1995-03-20
EP0442423A1 (de)	1991-08-21
DE69106543T2 (de)	1995-05-11
EP0442423B1 (de)	1995-01-11
IL97054A (en)	1995-10-31
HUT56496A (en)	1991-09-30
CA2036055A1 (en)	1991-08-13
ES2069758T3 (es)	1995-05-16
KR910015300A (ko)	1991-09-30
HK1005016A1 (en)	1998-12-18
JP3168543B2 (ja)	2001-05-21
JPH0826997A (ja)	1996-01-30
IL97054A0 (en)	1992-03-29
HU910436D0 (en)	1991-08-28
GR3015716T3 (en)	1995-07-31

Similar Documents

Publication	Publication Date	Title
FI913142A0 (fi)	1991-06-27	Migraenfoerhindrande alkoxipyrimidinderivat.
DE3780618D1 (de)	1992-08-27	Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
ES2052871T3 (es)	1994-07-16	Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
FI875795A7 (fi)	1988-10-16	Valonsäteilyttämislaite käytettäväksi nenän- ja nielun tiehyeiden lääketieteelliseen hoitoon.
DE69230654D1 (de)	2000-03-16	Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
DE69106543D1 (de)	1995-02-23	Verwendung von Buspiron in Schlaf-Apnoe.
DE3876846D1 (de)	1993-02-04	Morpholinderivate und deren verwendung.
DE69327813D1 (de)	2000-03-16	Alpha-Glucosyl-Catecholaminderivate, ihre Salze, Herstellung und Verwendung
FI915676L (fi)	1992-06-06	Substituerade n-bensoyl-n'- (2-fenyletyl)-piperaziner.
ATE25969T1 (de)	1987-04-15	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE69210727D1 (de)	1996-06-20	Verwendung von 1,2-Dipalmitoyl-L-Alpha-Phosphatidyl-N,N-Dimethylethanilamine in dermatologischen und kosmetischen Zusammensetzungen
DE68900867D1 (de)	1992-04-02	1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
ATE114464T1 (de)	1994-12-15	Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE69121210D1 (de)	1996-09-05	Therapeutische verwendung des fibroblastenwachstumsfaktors
DE59100375D1 (de)	1993-10-21	Abtastvorrichtung sowie Verwendung derselben.
FI923546A7 (fi)	1992-08-06	Tetraliini- ja kromaanijohdannaisia, jotka ovat käyttökelpoisia astman ,niveltulehduksen ja vastaavien sairauksien hoidossa
DE59207086D1 (de)	1996-10-17	Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
DE69011565D1 (de)	1994-09-22	Herstellung von Pre-Kaseinaten und Verwendung.
GR3002925T3 (en)	1993-01-25	Compound active in cardiovascular therapy
NO913237D0 (no)	1991-08-19	Fremgangsmaate og innretning for fremstilling av hoey ren 1,2-dikloretan med samtidig varmegjenvinning.
SE9403861D0 (sv)	1994-11-09	Novel medicinal use
DE69117566D1 (de)	1996-04-11	Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
GB2230443B (en)	1992-12-16	Treatment of sleep apnoea
DE68907971D1 (de)	1993-09-09	Verwendung von spergualin-derivaten gegen nebenwirkungen radiologischen oder medikamentoesen ursprungs.
KR910016422U (ko)	1991-10-26	환자 및 일반인 겸용 온열침구

Legal Events

Date	Code	Title	Description
1995-06-15	UEP	Publication of translation of european patent specification
2005-11-15	REN	Ceased due to non-payment of the annual fee